The corepressor CTBP2 is a coactivator of retinoic acid receptor/ retinoid X receptor in retinoic acid signaling

Molecular and Cellular Biology

Volumn 33, Issue 16, 2013, Pages 3343-3353

  Bajpe, Prashanth Kumar ^a   Heynen, Guus J J E ^a   Mittempergher, Lorenza ^a   Grernrum, Wipawadee ^a   Rink, Iris A de ^b   Nijkamp, Wouter ^a   Beijersbergen, Roderick L ^a   Bernards, Rene ^a   Huanga, Sidong ^a,c  

^a Divisions of Molecular Carcinogenesisa and Genomics Core Facility   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C TERMINAL BINDING PROTEIN 2; COREPRESSOR PROTEIN; HISTONE ACETYLTRANSFERASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ALCOHOL OXIDOREDUCTASES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CO-REPRESSOR PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; NERVE TISSUE PROTEINS; P300-CBP TRANSCRIPTION FACTORS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 84881280814     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01213-12     Document Type: Article

References (47)

1. Rochette-Egly C, Germain P. 2009. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl. Recept. Signal. 7:e005. doi:10.1621/nrs.07005.
2. Altucci L, Gronemeyer H. 2001. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1:181-193.
3. Freemantle SJ, Spinella MJ, Dmitrovsky E. 2003. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22: 7305-7315.
4. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
5. McKenna NJ, O'Malley BW. 2002. Nuclear receptor coactivators-an update. Endocrinology 143:2461-2465.
6. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
7. Wei LN. 2003. Retinoid receptors and their coregulators. Annu. Rev. Pharmacol. Toxicol. 43:47-72.
8. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
9. Chen JD, Evans RM. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
10. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. 1995. Ligandindependent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
11. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
12. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
13. Epping MT, Wang L, Edel MJ, Carlee L, Hernandez M, Bernards R. 2005. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122:835-847.
14. Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee HS, Eng F, Bertos NR, Pelletier N, Mader S, Han VK, Yang XJ, White JH. 2003. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11:139-150.
15. Perissi V, Jepsen K, Glass CK, Rosenfeld MG. 2010. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11: 109-123.
16. Chinnadurai G. 2009. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res. 69:731-734.
17. Chinnadurai G. 2007. Transcriptional regulation by C-terminal binding proteins. Int. J. Biochem. Cell Biol. 39:1593-1607.
18. Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G. 1993. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:469-478.
19. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. U. S. A. 92:10467-10471.
20. Subramanian T, La Regina M, Chinnadurai G. 1989. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene 4:415- 420.
21. Hildebrand JD, Soriano P. 2002. Overlapping and unique roles for Cterminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol. Cell. Biol. 22:5296-5307.
22. Holzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. 2010. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell 142:218-229.
23. Huang S, Laoukili J, Epping MT, Koster J, Holzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R. 2009. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell 15:328-340.
24. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
25. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R. 2004.Alarge-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428:431-437.
26. Brummelkamp TR, Fabius AW, Mullenders J, Madiredjo M, Velds A, Kerkhoven RM, Bernards R, Beijersbergen RL. 2006. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat. Chem. Biol. 2:202-206.
27. Bajpe PK, van der Knaap JA, Demmers JA, Bezstarosti K, Bassett A, van Beusekom HM, Travers AA, Verrijzer CP. 2008. Deubiquitylating enzyme UBP64 controls cell fate through stabilization of the transcriptional repressor Tramtrack. Mol. Cell. Biol. 28:1606-1615.
28. Reddy BA, Bajpe PK, Bassett A, Moshkin YM, Kozhevnikova E, Bezstarosti K, Demmers JA, Travers AA, Verrijzer CP. 2010. Drosophila transcription factor Tramtrack69 binds MEP1 to recruit the chromatin remodeler NuRD. Mol. Cell. Biol. 30:5234-5244.
29. Epping MT, Wang L, Plumb JA, Lieb M, Gronemeyer H, Brown R, Bernards R. 2007. A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 104:17777-17782.
30. Kortlever RM, Higgins PJ, Bernards R. 2006. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8:877-884.
31. Martens JH, Verlaan M, Kalkhoven E, Dorsman JC, Zantema A. 2002. Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol. Cell. Biol. 22:2598-2606.
32. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
33. Wang L, Feng Z, Wang X, Zhang X. 2010. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26:136-138.
34. Kim JH, Cho EJ, Kim ST, Youn HD. 2005. CtBP represses p300- mediated transcriptional activation by direct association with its bromodomain. Nat. Struct. Mol. Biol. 12:423-428.
35. Zhao LJ, Subramanian T, Chinnadurai G. 2006. Changes in C-terminal binding protein 2 (CtBP2) corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2. J. Biol. Chem. 281: 36613-36623.
36. Zhao LJ, Subramanian T, Zhou Y, Chinnadurai G. 2006. Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J. Biol. Chem. 281:4183-4189.
37. Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM. 2003. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl. Acad. Sci. U. S. A. 100:4568-4573.
38. Mroz EA, Baird AH, Michaud WA, Rocco JW. 2008. COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res. 68:6049-6053.
39. Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, Grossman SR. 2007. The alternative reading frame tumor suppressor antagonizes hypoxiainduced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res. 67:9322-9329.
40. Pena C, Garcia JM, Garcia V, Silva J, Dominguez G, Rodriguez R, Maximiano C, Garcia de Herreros A, Munoz A, Bonilla F. 2006. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int. J. Cancer 119:2098-2104.
41. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454.
42. Bhambhani C, Chang JL, Akey DL, Cadigan KM. 2011. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets. EMBO J. 30:2031-2043.
43. Fang M, Li J, Blauwkamp T, Bhambhani C, Campbell N, Cadigan KM. 2006. C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. EMBO J. 25:2735-2745.
44. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953.
45. Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR. 2002. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. U. S. A. 99:16701-16706.
46. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, Chanda SK, Downward J, Ellenberg J, Fraser AG, Hacohen N, Hahn WC, Jackson AL, Kiger A, Linsley PS, Lum L, Ma Y, Mathey-Prevot B, Root DE, Sabatini DM, Taipale J, Perrimon N, Bernards R. 2006. Minimizing the risk of reporting false positives in large-scaleRNAiscreens. Nat. Methods 3:777-779.
47. Zhao LJ, Kuppuswamy M, Vijayalingam S, Chinnadurai G. 2009. Interaction of ZEB and histone deacetylase with the PLDLS-binding cleft region of monomeric C-terminal binding protein 2. BMC Mol Biol 10:89. doi:10.1186/1471-2199-10-89.